NCT02813980View on ClinicalTrials.gov

Neural Circulatory Control and SUDEP Risk.

Active, not recruitingOBSERVATIONAL

Enrollment

39

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions

EpilepsySeizures

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

American Heart Association

OTHER

lead

Mayo Clinic

OTHER